Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Insiders Buy Shares at Achillion Pharmaceuticals, ChemoCentryx, and Walter Energy

By

Plus, a purchase at Accelrys.

PrintPRINT
Welcome to our daily roundup of top insider trades. Here's a look at the most significant inside purchases recently filed with the SEC.

Notable Purchases:
  • Boston-based investment adviser Ra Capital Management bought 1,186,007 shares of biopharmaceutical company Achillion Pharmaceuticals (NASDAQ:ACHN) for $2,902,711. Achillion focuses on the discovery, development, and commercialization of treatments for infectious diseases. This purchase was filed with the SEC on the same day -- Monday, September 30 -- as a major sale of company stock by QVT Associates GP LLC.
  • The private equity firm BVF Partners LP bought 336,225 shares of biopharmaceutical company ChemoCentryx (NASDAQ:CCXI) for $1,676,808. ChemoCentryx develops oral-administered therapeutics for the treatment of autoimmune diseases, inflammatory diseases, and cancer.
  • The investment firm RGM Capital bought 119,460 shares of scientific informatics company Accelrys (NASDAQ:ACCL) for $1,111,992.
  • David Beatty, a director at metallurgical coals producer and exporter Walter Energy (NYSE:WLT), bought 10,000 shares of company stock for $168,700.

For more insider trades, see the charts below.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
DIR
AB
$3,625,176
2
BO
B
$2,902,711
3
BO
B
$1,676,808
4
BO
B
$1,111,992
5
BO
JB*
$1,100,000
6
DIR
JB*
$650,000
7
DIR,BO
B
$568,710
8
CEO,CB,BO
B
$345,598
9
CEO,DIR
JB*
$280,000
10
DIR
B
$168,700

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
DIR
AS
$142,506,400
2
BO
JS*
$109,326,912
3
DIR,BO
JS*
$49,000,000
4
PR
S
$6,924,840
5
DIR
N
S
$2,938,957
6
CEO,DIR
AS
$2,722,920
7
DIR
S
$2,460,587
8
VP,COO
S
$2,146,000
9
DIR
S
$1,993,553
10
VP,CFO
S
$1,567,923

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

An important note from Jonathan Moreland, founder of Insider Insights:

In a victory for common sense, it has been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders."

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

Jonathan Moreland is also the author of "Profit From Legal Insider Trading."
< Previous
  • 1
Next >
No positions in stocks mentioned.
PrintPRINT

Busy? Subscribe to our free newsletter!

Submit
 

WHAT'S POPULAR IN THE VILLE